The Evaluation of a Mask Seal/Mask for the Treatment of Obstructive Sleep Apnea (OSA)
The Evaluation of a Mask for the Treatment of Obstructive Sleep Apnea (OSA)
1 other identifier
interventional
18
1 country
1
Brief Summary
This investigation is designed to evaluate the performance as well as the patients overall acceptance of the seal/mask.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2017
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 22, 2017
CompletedStudy Start
First participant enrolled
March 27, 2017
CompletedFirst Posted
Study publicly available on registry
March 28, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 3, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
August 3, 2017
CompletedAugust 8, 2017
August 1, 2017
4 months
March 22, 2017
August 6, 2017
Conditions
Outcome Measures
Primary Outcomes (4)
Ease of use
Subjective questionnaire
1 week in home
Acceptability
Subjective questionnaire
1 week in home
Ease of use
Subjective questionnaire
2 weeks in home
Acceptability
Subjective questionnaire
2 weeks in home
Secondary Outcomes (1)
Objective leak data
1 week in home
Study Arms (2)
F&P Mask Seal
EXPERIMENTALParticipants to use trial seal in-home for 1 week
F&P Mask
EXPERIMENTALParticipants to use trial mask in-home for 2 weeks
Interventions
Eligibility Criteria
You may qualify if:
- Adult (18+ years of age)
- Able to give consent
- Apnea hypopnea Index (AHI)≥ 5 on diagnostic night
- Prescribed PAP for OSA
- Existing oro-nasal mask user
You may not qualify if:
- Inability to give consent
- Patients who are in a coma or a decreased level of consciousness
- Anatomical or physiological conditions making automatic positive airway pressure (APAP) therapy inappropriate (e.g. unconsolidated facial structure)
- Commercial drivers who are investigated by New Zealand Transport Agency
- Current diagnosis of carbon dioxide (CO2) retention
- Pregnant or may think they are pregnant
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fisher & Paykel Healthcare
Auckland, 2013, New Zealand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sarah Gunson
Employee
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2017
First Posted
March 28, 2017
Study Start
March 27, 2017
Primary Completion
August 3, 2017
Study Completion
August 3, 2017
Last Updated
August 8, 2017
Record last verified: 2017-08
Data Sharing
- IPD Sharing
- Will not share
For product development purposes only. Data will be deidentified.